Angiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysis.
Chen XL; Lei YH; Liu CF; Yang QF; Zuo PY; Liu CY; Chen CZ; Liu YW; Plos One, 2013, vol. 8, issue 6, p e66721, ISSN 19326203. ISBN 19326203.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef